Atrial Fibrillation Trial, Recruiting NCT05790707 Sponsor: Poitiers University Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05790707
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 60 and 80 years old
  • People who have been diagnosed with persistent atrial fibrillation (an irregular heart rhythm that doesn't stop on its own)
  • People whose doctor has recommended treatment to restore a normal heart rhythm
  • People who have scored between 18 and 25 points on a standard memory and thinking test called the Montreal Cognitive Assessment, which corresponds to mild cognitive impairment
  • People who are not under any form of legal guardianship or supervision by another person
  • People who are able to understand and agree to follow the requirements of the study
  • People who are covered by French national health insurance, either directly or through a third party
  • People who have given written consent to take part after receiving full information about the study

Who may not be able to join:

  • People who are unable to complete the thinking and memory tests, for example due to hearing loss, difficulty speaking, or a language barrier
  • People who have previously had a stroke
  • People who have had a sound detected in the neck arteries during examination, or who have a history of severe narrowing of the neck arteries (carotid stenosis)
  • People with a known or suspected history of a brain or nerve condition such as Parkinson's disease, Alzheimer's disease, Huntington's disease, or ALS, or a history of bipolar disorder, schizophrenia, severe depression, or a condition called amyloidosis
  • People who have previously had a procedure to treat atrial fibrillation by ablation (a treatment that uses energy to destroy small areas of heart tissue causing the irregular rhythm)
  • People currently having an ablation procedure for flutter or atrial tachycardia (other types of irregular heart rhythm, not atrial fibrillation)
  • People for whom atrial fibrillation ablation is not medically safe, for example due to a blood clot in the heart, severe high blood pressure in the lungs, a mechanical heart valve, or a reason they cannot take blood thinners
  • People who cannot safely take anti-arrhythmic medications (medicines used to control heart rhythm) or have a medical reason they cannot have a small heart monitor implanted under the skin
  • People whose atrial fibrillation has been present for more than 3 years, or whose heart measurements show the heart's upper left chamber is very enlarged (confirm with trial site for specific measurements)
  • People whose life expectancy at the time of enrolment is less than 24 months
  • People who are not able to give informed consent to participate
  • People in legally protected categories, including minors, people detained by legal or administrative order, adults under legal protection, or people in emergency medical situations
  • Women who are pregnant or breastfeeding, and women of childbearing age who are not using an effective form of contraception (such as hormonal methods, barrier methods, an intrauterine device, or surgical procedures such as tubal ligation or hysterectomy)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 549443729

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poitiers University Hospital
Registry
ClinicalTrials.gov
Start date
21 April 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Montreal Cognitive Assessmentquestionnaire score evolution 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov